Publisher Correction: PRKCSH contributes to tumorigenesis by selective boosting of IRE1 signaling pathway
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Main Authors: | Gu-Choul Shin, Sung Ung Moon, Hong Seok Kang, Hyo-Sun Choi, Hee Dong Han, Kyun-Hwan Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2019-08-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-019-11824-3 |
Similar Items
-
PRKCSH contributes to tumorigenesis by selective boosting of IRE1 signaling pathway
by: Gu-Choul Shin, et al.
Published: (2019-07-01) -
PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer
by: Gu-Choul Shin, et al.
Published: (2024-01-01) -
PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer
by: Qiankun Wang, et al.
Published: (2024-01-01) -
Navigating PRKCSH’s impact on cancer: from N-linked glycosylation to death pathway and anti-tumor immunity
by: Ratchada Cressey, et al.
Published: (2024-03-01) -
Adjuvant effect of IRES-based single-stranded RNA on melanoma immunotherapy
by: Hye Won Kwak, et al.
Published: (2022-10-01)